Non-invasive ventilation for cystic fibrosis

Area of Science:

• Respiratory Medicine
• Pulmonology
• Medical Technology

Background:

• Non-invasive ventilation (NIV) is explored for managing respiratory failure in cystic fibrosis (CF).
• NIV aims to temporarily reverse or slow the progression of worsening respiratory function in CF patients.

Purpose of the Study:

• To compare the effects of non-invasive ventilation (NIV) versus no NIV in individuals with cystic fibrosis (CF).

Main Methods:

• Searched the Cochrane Cystic Fibrosis and Genetic Disorders Group trials register and reference lists for relevant randomized controlled trials.
• Included trials evaluating pressure-preset or volume-preset NIV against no NIV in acute or chronic respiratory failure in CF.
• Two independent reviewers assessed trials for inclusion, quality, and data extraction.

Main Results:

• Four trials with 55 participants evaluated single treatment sessions.
• NIV may facilitate airway clearance and be preferred by CF patients, but did not increase sputum expectoration or improve lung function in short-term airway clearance trials.
• Overnight NIV support trials showed no clear differences compared to oxygen or room air for lung function, with discrepancies noted due to small sample sizes and varied statistical methods.

Conclusions:

• NIV could be a beneficial adjunct for airway clearance in CF patients, especially those with difficulty expectorating sputum.
• Overnight NIV with oxygen may enhance gas exchange in moderate to severe CF, but long-term efficacy, safety, and acceptability remain unproven.
• Long-term randomized controlled trials are necessary to establish the clinical effects of NIV in cystic fibrosis.